Clinical trial
Study to Evaluate the Safety and Efficacy of EUR-1008 (APT-1008) Pancreatic…
NCT00297167 · Forest Laboratories, Industry · Completed
Key facts
| NCT number | NCT00297167 |
|---|---|
| Title | Study to Evaluate the Safety and Efficacy of EUR-1008 (APT-1008) Pancreatic Enzyme Product in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Two-Treatment, Crossover Study to Evaluate the Safety and Efficacy of Eurand Pancreatic Enzyme Product (PEP) in Patients With Cystic Fibrosis and Exocrine Pancreatic Insufficiency |
| Lead sponsor | Forest Laboratories, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis, Exocrine Pancreatic Insufficiency |
| Intervention type | Drug |
| Interventions | EUR-1008 (APT-1008), Placebo |
| Enrollment | 34 |
| Start date | May 1, 2006 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Feb 28, 2006 |
| Last update posted | Mar 16, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: